ILOSONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ilosone, and what generic alternatives are available?
Ilosone is a drug marketed by Lilly and Dista and is included in seven NDAs.
The generic ingredient in ILOSONE is erythromycin estolate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin estolate; sulfisoxazole acetyl profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ILOSONE?
- What are the global sales for ILOSONE?
- What is Average Wholesale Price for ILOSONE?
Summary for ILOSONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 2,464 |
| DailyMed Link: | ILOSONE at DailyMed |
US Patents and Regulatory Information for ILOSONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | ILOSONE | erythromycin estolate | CAPSULE;ORAL | 061897-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | ILOSONE | erythromycin estolate | SUSPENSION;ORAL | 061894-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | ILOSONE | erythromycin estolate | SUSPENSION/DROPS;ORAL | 061894-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
